IDXX · Earnings call · 2026Q2T · Full report

Market Demand Trends

IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 25 · Surprise 32

U.S. same-store clinical visits declined 1.3% in Q2, with wellness visits down more than 3% while non-wellness visits showed modest growth. Pets aged five and older generated positive growth across both wellness and non-wellness visits, supporting diagnostic demand despite weaker overall visit volume. IDEXX reported nearly 10% U.S. CAG Diagnostics recurring-revenue growth and nearly 12% international growth, reflecting higher diagnostic frequency, broader testing menus, and increased utilization per visit.

Key facts

• U.S. same-store clinical visits declined an estimated 1.3% in the quarter.